SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Veloxis Pharmaceuticals A/S' Phase 3 Trial of LCP-Tacro™ in Stable Kidney Transplant Patients, the 3001 Study, Published Online in the American Journal of Transplantation